MYCN and neuroblastoma: Since this approach promises to be an interesting opportunity for the treatment of high-risk MNA NBs, a better understanding of the molecular mechanisms governing the MYCN-dependent apoptosis-sensitive phenotype and the regulation of cell death following p53 reactivation urges in the perspective of a tailored p53 reactivation therapy of NB.